AASLD

04/03/2026

Break through the barriers holding you back 🔓
Join the Women’s Initiative Committee (WIC) on April 14 at noon EDT for this empowering webinar series on managing imposter syndrome and microaggressions. Discover how to recognize self-doubt, reframe negative thoughts, and build lasting confidence.
Register today 👉 https://bit.ly/4bZojYY

04/03/2026

We’re pleased to spread the word about the International Liver Transplantation Society (ILTS) in Geneva, May 6-9.

Join the global community for cutting-edge science, hands-on workshops, and multidisciplinary exchange.

Learn more: ilts.org/2026-congress

04/02/2026

At DDW® 2026, add AASLD hepatology programming to your schedule and dive deeper into the gut-liver connection.

Highlights include:

🎟️ Basic Science Emerging Topic Conference exploring the gut-liver axis and systems biology driving MASLD, MASH, ALD, and cholestatic disease.

🎟️ Point-of-Care Ultrasound hands-on training available. The morning session is sold out, and a few seats remain in the afternoon.

Register Today: https://bit.ly/3OPoGNP

04/02/2026

There is still time to register for the 2026 held in Bangkok, Thailand on Apr. 28-30.

Register online today! https://bit.ly/4sEMDXN

04/02/2026

Featuring cutting-edge research, expert reviews, and clinically relevant insights, this Transplantation National Month collection highlights key challenges and innovations across the transplant field.

Explore the latest advances: https://bit.ly/3zp3Tpg.

04/01/2026

Explore the critical topic of kratom-associated liver injury next Thursday. Jawad Ahmad, MD, and David E. Kleiner, MD, PhD, will cover clinical features, pathology, and emerging research, including a detailed case study.

Save your spot 👉 https://www.aasld.org/april-hepatotoxicity-sig-seminar-kratom-associated-liver-injury

04/01/2026

LAST DAY: Peer and self-nominations are open for the 2026 AASLD Distinguished Awards through 11:59 PM EDT. Don't miss your last chance to recognize individuals whose contributions are advancing liver health and strengthening the hepatology community.

Submit your nomination today:

Every year at The Liver Meeting® (TLM), AASLD recognizes the exceptional members of our community whose work has advanced hepatology. Through the Distinguished Awards, AASLD’s most prestigious honors, we celebrate outstanding scientific achievement, clinical excellence, and enduring contributions...

04/01/2026

April is .

Alcohol-associated liver disease remains a major global health challenge, but the science to better understand, prevent, and treat it is rapidly advancing. Research published in AASLD journals is shaping the future of and improving outcomes for patients worldwide.

View the collection featuring articles from , , and : https://bit.ly/4bQMU1X.

03/31/2026

It’s time to ELEVATE your research at The Liver Meeting®! Engage with the global hepatology community and share your work.

📅 Deadline: May 28, 11:59 p.m. EDT

🔗 Submission Portal: https://bit.ly/4cbiJnu

Are you an early career investigator? Apply for travel awards during submission!

03/30/2026

AASLD is featured in this Healio Gastroenterology article for supporting a federal court decision that safeguards childhood and vaccinations.

The ruling protects longstanding, evidence-based immunization practices that are critical to preventing , chronic infection, and .

View the full article here: https://bit.ly/3NCjqNs.

The American Association for the Study of Liver Diseases supports a court ruling that temporarily blocks changing the childhood and adolescent immunization schedule, including the hepatitis B birth and childhood hepatitis A vaccinations.The ruling, made by U.S. District Judge Brian E. Murphy on Marc...

03/30/2026

This , AASLD celebrates the hepatologists and physician-scientists whose expertise, compassion, and dedication advance every day.

Your work drives discovery, improves patient outcomes, and brings us closer to a future free from liver disease.

03/27/2026

AASLD is launching a new national initiative to improve the early detection of liver fibrosis and MASLD. Through this effort, we will convene experts across disciplines to develop consensus recommendations and practical strategies for systematic liver disease detection. Boehringer Ingelheim serves as the lead supporter and primary funding partner for the project.

“AASLD is proud to lead this effort by convening experts and partners across the healthcare ecosystem to advance practical solutions for earlier detection and better patient outcomes,” said Saul J. Karpen, MD, PhD, FAASLD, President of AASLD.

Earlier detection means more opportunities to connect patients with appropriate care and improve long-term outcomes.

Learn more: https://bit.ly/41tjtye